AvalehtBBN • SWX
add
Bellevue Group AG
Viimane sulgemishind
14,10 CHF
Tänane vahemik
13,50 CHF - 14,15 CHF
Aasta vahemik
11,05 CHF - 24,30 CHF
Turuväärtus
181,73 mln CHF
Keskmine maht
9,33 tuh
P/E suhe
12,18
Dividendimäär
8,52%
Põhibörs
SWX
Börsiuudised
NVDA
0,00%
0,00%
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(CHF) | juuni 2024info | Y/Y muutus |
---|---|---|
Käive | 18,41 mln | −11,31% |
Põhitegevusega seonduv kulu | 13,73 mln | −10,56% |
Puhastulu | 3,72 mln | −7,22% |
Puhaskasumimarginaal | 20,18 | 4,61% |
Puhaskasum aktsia kohta | — | — |
EBITDA | — | — |
Tõhus maksumäär | 17,26% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(CHF) | juuni 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 30,49 mln | 100,63% |
Kogu vara | 138,75 mln | −4,69% |
Kõik kohustused | 22,05 mln | −24,81% |
Kogu omakapital | 116,70 mln | — |
Emiteeritud aktsiate arv | 13,20 mln | — |
Hinna ja väärtuse suhe P/B | 1,60 | — |
Varade tasuvus | 10,71% | — |
Kapitali tasuvus | — | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(CHF) | juuni 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 3,72 mln | −7,22% |
Põhitegevuse rahakäive | 3,65 mln | 137,31% |
Investeeringute raha | — | — |
Finantseerimise raha | −8,10 mln | 45,85% |
Raha ja raha ekvivalentide muutus | −4,17 mln | 83,13% |
Tasuta rahavoog | — | — |
Teave
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Tegevjuht
Asutatud
1993
Veebisait
Töötajate arv
88